The TU/e has developed a technique that will make it possible to control the amount of medication that is let loose in a specific patients body. A DNA-computer that can determine the effectivity a medicine has with a patient.
The research team has published an article on this in Nature Communications this Friday. Researchers that were involved in the process have named the development of the technique an important step in the development of ‘self-thinking’ medication.
According to the university, the technique should be able to help medicate rheumatism and Crohns disease in the long-term. With fewer side-effects and lower costs as a result.
The researchers compare the system to a security system that will act on its own, determining whether it is safe to open a door, depending on what person is in front of the camera. The developed system does the same. It recognizes whether a patient needs more or less medication and will release that amount.
Innovation Origins is an independent news platform, which has an unconventional revenue model. We are sponsored by companies that support our mission: spreading the story of innovation. Read more here.
On Innovation Origins you can always read articles for free. We want to keep it that way. Have you enjoyed this article so much that you want to thank the author? Click here: